This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
MABTECH
product type :
ELISA/assay
product name :
Human IFN-gamma/Granzyme B FluoroSpotPLUS kit
catalog :
FSP-0110-2
quantity :
2 plates
price :
770 USD
citations: 13
Reference |
---|
product information
Product Code :
FSP-0110-2
Product Name :
Human IFN-gamma/Granzyme B FluoroSpotPLUS kit
Categories :
FluoroSpot Kits
Size :
2 plates
Size Number :
2
Size Unit :
plates
EUR :
650
USD :
770 USD
GBP :
575
AUD :
1050
SEK :
6800
Format :
pre-coated plates
Cell Type :
T cells
Application :
FluoroSpot
Reactivities :
human, human
Analytes :
IFNG, Granzyme B, Granzyme B, IFNG
Recommended Products :
FSP-011009-2
Contents :
BAM-conjugated detection mAb (7-B6-1),Biotinylated detection mAb (GB11),Anti-BAM-490,SA-550,anti-CD3 mAb,Anti-CD28 mAb (CD28-A),Fluorescence enhancer,Pre-coated FluoroSpot plates (mAb 1-D1K and GB10)
Product Header :
FluoroSpot kit with pre-coated plates for enumeration of cells secreting IFN-γ and Granzyme B
Description 1 :
The FluoroSpot assay is an inventive development of the ELISpot assay and uses fluorescent detection instead of colorimetric. This allows for simultaneous detection of several analytes, which is a major advantage. The human IFN-γ/Granzyme B FluoroSpot kit is perfect for users who wish to have a convenient assay with minimized assay variability. It enables enumeration of cells secreting either one or both analytes and includes low fluorescent plates pre-coated with monoclonal capture antibodies, monoclonal detection antibodies, secondary reagents conjugated to fluorophores, a fluorescence enhancer and an anti-CD28 monoclonal antibody for co-stimulation. A polyclonal activator for human T cells (mAb CD3-2) is supplied as a positive control for cytokine secretion.
Description 2 :
Pre-coated plates enable a more rapid assay with minimized variability.
References :
Jelcic, I., et al. (2018). Memory B Cells Activate Brain-Homing, Autoreactive CD4(+) T Cells in Multiple Sclerosis. Cell. (http://www.ncbi.nlm.nih.gov/pubmed/30173916)
Bronge, M., et al. (2019). Myelin oligodendrocyte glycoprotein revisited-sensitive detection of MOG-specific T-cells in multiple sclerosis. Journal of autoimmunity. (http://www.ncbi.nlm.nih.gov/pubmed/31054941)
Jackson, S. E., et al. (2017). HCMV Specific CD4+ T Cells are poly-functional and can respond to HCMV Infected Dendritic Cells in vitro. Journal of virology. (http://www.ncbi.nlm.nih.gov/pubmed/28053099)
Fostier, K., et al. (2018). Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation. Oncotarget. (http://www.ncbi.nlm.nih.gov/pubmed/29755666)
Liebowitz, D., et al. (2020). Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study. Lancet Infect Dis. (http://www.ncbi.nlm.nih.gov/pubmed/31978354)
Shelf Life :
12 months
Last updated :
2013-07-01
company information

MABTECH
Box 1233
SE-131 28 Nacka Strand
SE-131 28 Nacka Strand
mabtech@mabtech.com
http://www.mabtech.com1 866 354-7768
headquarters: Sweden
questions and comments